Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
Abstract 4: Validation of a novel xenograft mouse model for intestinal fistulas
Year: 2018
Source: 4th Y-ECCO Basic Science Workshop
Authors: Bruckner Ramona
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
Abstract 5: Targeting fibroblast activation protein in Crohn's Disease intestinal strictures restores balanced deposition of extracellular matrix and reduces fibrosis
Year: 2018
Source: 4th Y-ECCO Basic Science Workshop
Authors: Truffi Marta
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
10: Abstract 2: Introduction of an Inflammatory Bowel Disease nurse flexible sigmoidoscopy clinic improves patient care by initiating earlier treatment and saves clinic slots
Year: 2016
Source: 10th N-ECCO Network Meeting
Authors: Johnson H.
FATIGUE, PSYCHOLOGICAL CO-MORBIDITY
Files: 1
10: Best abstract: Gene expression profiling indicates similar molecular pathways are active in adult and paediatric Crohn’s Disease
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Stojmirovic A.
genetics, paediatric, Crohn's Disease
Files: 1
10: Do nothing and refer to the gastroenterologist
Year: 2016
Source: 5th S-ECCO IBD Masterclass
Authors: Shwaartz C.
Crohn's Disease,
Files: 1
10: Non-IBD colitides
Year: 2016
Source: 1st H-ECCO IBD Masterclass
Authors: Langner C.
Last Modified: Wednesday, 23 January 2019, 11:03 AM by ECCO Administrator
IBDU, infectious colitis, ischaemic colitis, histology
Files: 1
10: Nursing roles in IBD management
Year: 2016
Source: 7th N-ECCO School
Authors: White L.
NURSING
Files: 1
10: Tandem talk: IBD therapeutics targets and drugs: New and old
Year: 2016
Source: 14th IBD Intensive Advanced Course
Authors: Chowers Y., Lindsay J.
TREAT TO TARGET
Files: 1
10: The evidence for fibre and prebiotics in IBD
Year: 2016
Source: 1st D-ECCO Workshop
Authors: Whelan K.
clincal trials, IBS, microbiota, probiotic therapy, nutrition, prebiotics
Files: 1
10: The role of DNA methylation
Year: 2016
Source: EU Project Forum
Authors: Ventham N.
EPIGENETICS, GENETICS, IMMUNOLOGY
Files: 1
10: What are conventional treatment options?
Year: 2016
Source: 3rd Basic ECCO: EduCational COurse for Industry
Authors: Zagorowicz E.
MESALAZINE, Ulcerative Colitis, Crohn's Disease
Files: 1
11: Abstract 3: Proving cost effectiveness through implementation of a nurse-led Inflammatory Bowel Disease (IBD) Patient Advice Line and Virtual Clinic (CHEAP)
Year: 2016
Source: 10th N-ECCO Network Meeting
Authors: Sechi A.
Files: 1
11: Cancer risk in IBD
Year: 2016
Source: 1st H-ECCO IBD Masterclass
Authors: Villanacci V.
colorectal cancer surveillance, complications
Files: 1
11: Case based discussion: Fistulising Crohn’s Disease: Medical and surgical approaches
Year: 2016
Source: 14th IBD Intensive Advanced Course
Authors: López-Sanromán A., D'Hoore A.
Crohn's Disease, PERIANAL FISTULA, ABSCESS, NON PERIANAL FISATULA, THIOPURINES, ANTI TNF AGENTS
Files: 1
11: The potential of glycomics as an IBD biomarker
Year: 2016
Source: EU Project Forum
Authors: Lauc G., Wuhrer M.
Crohn's Disease, Ulcerative Colitis
Files: 1
11: Video - Strictureplasty of the ileocolic valve
Year: 2016
Source: 5th S-ECCO IBD Masterclass
Authors: D'Hoore A.
stricturoplasty, Crohn's Disease
Files: 1
11: What is the role of 5-ASA?
Year: 2016
Source: 3rd Basic ECCO: EduCational COurse for Industry
Authors: Mantzaris G.
Last Modified: Friday, 21 May 2021, 12:33 PM by Admin User
MESALAZINE, Ulcerative Colitis, Crohn's Disease
Files: 1
12: Best abstract: A variable number of tandem repeat polymorphism in the promotor region of the neonatal Fc receptor affects anti-TNF serum levels in IBD
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Billiet T.
adalimumab, anti-TNF agents, genetics, Crohn's Disease, Ulcerative Colitis, infliximab, pharmacokinetics, therapeutic drug monitoring,
Files: 1
12: Case based discussion: The patient with severe inflammatory Crohn’s Disease
Year: 2016
Source: 14th IBD Intensive Advanced Course
Authors: Hindryckx P., Laurence E.
Anti-TNF agents, Corticosteroids, Ustekinumab, Vedolizumab
Files: 1
12: Is it time to welcome the new buddies? A debate on biosimilars
Year: 2016
Source: 10th N-ECCO Network Meeting
Authors: Danese S., Michetti P.
ANTI-TNF AGENTS, Crohn's Disease, Ulcerative Colitis
Files: 1